An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

Vaccine

Volumn 24, Issue 16, 2006, Pages 3063-3065

  Giudice, Giuseppe Del ^a   Hilbert, Anne Katrin ^b   Bugarini, Roberto ^a   Minutello, Ada ^a   Popova, Olga ^a   Toneatto, Daniela ^a   Schoendorf, Ines ^b   Borkowski, Astrid ^b   Rappuoli, Rino ^a   Podda, Audino ^a  

^a CHIRON VACCINES   (Italy)

^b Chiron Vaccines   (Germany)

Author keywords

Adjuvant; Heterovariant; Influenza; Vaccine

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;

ADULT; AGED; ARTICLE; CONSERVATIVE TREATMENT; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLUENZA VIRUS A; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; POLYSORBATES; SQUALENE; VACCINES, INACTIVATED; VACCINES, SUBUNIT;

EID: 33645058168     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.015     Document Type: Article

References (8)

1. CDC Update: influenza activity - United States, December, 14-20, 2003. MMWR 2004;52:1255-7.
2. A. Ault Shifting tactics in the battle against influenza Science 203 2004 1280
3. CDC. Update: influenza-associated deaths reported among children aged <18 years - United States, 2003-2004 influenza season. MMWR 52:1286-88.
4. CDC. Preliminary assessment of the effectiveness of the 2003-2004 inactivated influenza vaccine - Colorado, December 2003. MMWR 2004;53:8-11.
5. C.W. Potter, and J.S. Oxford Determinants of immunity to influenza infection in man Br Med Bull 35 1979 69 75
6. WHO. Recommended composition of influenza virus vaccines for use in the 2004-2005 influenza season. Weekly Epidemiol Rec 2004;79:88-92.
7. A. Podda The adjuvanted influenza vaccines with novel adjuvants: experience with MF59-adjuvanted vaccine Vaccine 19 2001 2673 2680
8. I. Stephenson, R. Bugarini, K.G. Nicholson, A. Podda, J.M. Wood, and M. Zambon Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy J Infect Dis 191 2005 1210 1215